New Global Alliance Aims To Speed Up Academic Drug Discovery

Published by Adeline Siew on January 24, 2013 12:53 pm under R&D

 

Six of the world’s leading health research centres have joined forces to form a global alliance that seeks to strengthen international academic and not-for-profit drug development. The aim of the Global Alliance of Leading Drug Discovery and Development Centres, which consists of organisations from Europe and North America, is to accelerate the translation of academic research into usable medicines and therapies.

 

The founding organisations include:

• The Centre for Drug Research and Development (CDRD), Canada
• Lead Discovery Centre (LDC), Germany
• The Scripps Research Institute, Scripps Florida, United States
• The Centre for Drug Design and Discovery (CD3), KU Leuven R&D, Belgium
• Medical Research Council (MRC) Technology, United Kingdom
• Cancer Research Technology (CRT), United Kingdom

New Global Alliance Aims To Speed Up Academic Drug Discovery

PCORI - Call for Topics and Research Prioritization Methods - Workshops Dec 4 & 5

December 3, 2012 The Patient-Centered Outcomes Research Institute (PCORI) will host workshops tomorrow and Wednesday to solicit input from patients, researchers and other healthcare stakeholders on its draft process for generating and selecting specific research topics. On Tuesday, December 4, PCORI will hold a workshop called " What Should PCORI Study? A Call for Topics from Patients and Stakeholders." The event will solicit recommendations from a diverse group of healthcare stakeholders for specific topics to consider for funding and feedback on PCORI's plans for engaging stakeholders in the research process.   On Wednesday, December 5, the institute will host the "PCORI Research Prioritization Methods Workshop." During this event, research methodologists, patients and other stakeholders will share best practices for improving research prioritization methods and help PCORI refine its proposed prioritization process to see that it addresses the needs of patients and those who care for them.   You can participate in each workshop through:   A free webcast. Register to view both workshops here: www.webcastregister.com/pcori  Tuesday's webcast will be live from 8:00-10:45 a.m. and 3:00-5:00 p.m. Wednesday's webcast will be live from 8:30-11:30 a.m. and 12:30-4:30 p.m. An archive of both workshop webcasts will be available on the PCORI website after the events Join the conversation via Twitter using the #PCORI hashtag. "Suggest a Question" that PCORI can consider as it develops targeted research funding announcements. Submit additional feedback via email to getinvolved@pcori.org. Please visit each workshop event page for more information, including agendas and information on presenters and participants.   ### About PCORI The Patient-Centered Outcomes Research Institute (PCORI) is an independent, non-profit organization authorized by Congress in 2010. Its mission is to fund research that will provide patients, their caregivers and clinicians with the evidence-based information needed to make better-informed health care decisions. PCORI is committed to continuously seeking input from a broad range of stakeholders to guide its work. More information is available at www.pcori.org.   Patient-Centered Outcomes Research Institute | 1828 L Street, NW | Suite 900 | Washington | DC | 20036

Doctors versus “Big Pharma”: is it justifiable to judge research by its authors?

By Ilana Yurkiewicz | October 27, 2012

 

Doctors use different standards to judge scientific research depending on who funded it. They judge research funded by industry as less rigorous, have less confidence in the results, and are less likely to prescribe new drugs than when the funding source is either the NIH or unknown – even when the apparent quality of the research is the same.

 

Those were the results of a study published by Harvard researchers Dr. Aaron Kesselheim and colleagues in the New England Journal of Medicine last month. The story has received a fair amount of coverage since then, including being analyzed by the Scientific American Guest Blog, the Los Angeles Times, and the New York Times.

There’s a question of ethical and practical relevance embedded in this: is it justifiable to judge a paper by its author or funding source – even when you cannot discern a difference in quality?

for complete article, see link above.

DIA/FDA: Revitalizing Productivity in Drug Development

DIA/FDA: Revitalizing Productivity in Drug Development October 23-24 | Bethesda, MD Explore Initiatives that Champion Research & Development Productivity Review the status quo of the pharmaceutical industry and explore the initiatives that champion the continued revitalization of R&D productivity in drug development. This two-day conference will provide a forum for industry, regulators, and academia to come together to discuss challenges and opportunities, share visions, experiences, and lessons learned, as well as successes and failures in the challenging journey of drug development.   Keynote Speakers: Keynote Address I - Revitalizing R&D: What Could We Be Doing Differently? Robert J. Temple, MD, Deputy Center Director for Clinical Science, CDER, FDA   Keynote Address II - An Overview of the Future for Drug Development Under the New Imperatives Delivered by Both Commercial and Regulatory Pressures Stephen A. Arlington, PhD, Partner, Global Pharmaceutical and Life Sciences, Advisory Services Leader, PricewaterhouseCoopers LLP   Keynote Address III - How Do We Revitalize R&D in New Drug Development? Frank W. Rockhold, PhD, Senior Vice President, Global Clinical Safety and Pharmacovigilance, GlaxoSmithKline   Keynote Address IV - Collaborative Approaches to Advancing Clinical Development Charles G. Beever, MBA, Vice President, Booz and Company    Program Overview | Register Now

PCORI wants to know what health care question or decision you may be facing - SURVEY

The Patient-Centered Outcomes Research Institute (PCORI) wants to know what health care question or decision you may be facing. Your input can help us refine our research agenda.

Patients, caregivers and the broader health care community are invited to complete a survey on our website to propose specific research questions. Each suggestion we receive will be carefully evaluated through a selection process that will lead to targeted announcements for research funding.   In addition to questions about prevention, diagnosis and treatment options, we'd like to know what information you need that could help us fund research to improve health care delivery, address disparities of all types, improve how research is communicated , or even improve the research process overall.   One example of a proposed research question is: "Should I see my primary care physician, an orthopedic specialist, or chiropractor for the best care related to my chronic lower back pain?"   That's an actual question we received through the form.   Join us! Please take a few minutes to submit your research questions and become part of PCORI's efforts to change the research process by making the patient's voice a central piece of how our work is done.   About PCORI The Patient-Centered Outcomes Research Institute (PCORI) is an independent, non-profit organization authorized by Congress. Its mission is to fund research that will provide patients, their caregivers and clinicians with the evidence-based information needed to make better-informed health care decisions. PCORI is committed to continuously seeking input from a broad range of stakeholders to guide its work. More information is available at www.pcori.org.